Edition:
United Kingdom

CytRx Corp (CYTR.OQ)

CYTR.OQ on NASDAQ Stock Exchange Capital Market

0.60USD
19 Feb 2019
Change (% chg)

$0.00 (+0.35%)
Prev Close
$0.60
Open
$0.61
Day's High
$0.61
Day's Low
$0.59
Volume
28,064
Avg. Vol
27,710
52-wk High
$2.18
52-wk Low
$0.35

Chart for

About

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The Company is focused on the clinical development of aldoxorubicin, its modified version of the chemotherapeutic agent, doxorubicin. It is engaged in Phase III trials for aldoxorubicin as a therapy for patients with soft tissue... (more)

Overall

Beta: 2.34
Market Cap(Mil.): $69.25
Shares Outstanding(Mil.): 165.83
Dividend: --
Yield (%): --

Financials

  CYTR.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -0.41 -- --
ROI: -112.76 8.92 14.45
ROE: -214.05 10.08 15.96

Earnings vs. Estimates